Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Exela Pharma Sciences LLC has 1 pending office action in Biotechnology & Pharmaceuticals. The action is assigned to 1 examiner and 1 art unit, so the available prosecution data reflects a single examination path rather than multiple parallel assignments.
JUSTICE, GINA CHIEUN YU is the busiest examiner, with 1 pending action. The examiner-level and art-unit concentration means that counsel can focus review on one prosecution record, one examiner’s practice, and one unit’s examination context.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JUSTICE, GINA CHIEUN YU | 1 | 55.6% | +8.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18957493 | GANCICLOVIR COMPOSITIONS AND RELATED METHODS | JUSTICE, GINA CHIEUN YU | — |
| Art Unit | Apps |
|---|---|
| 1617 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18957493 | GANCICLOVIR COMPOSITIONS AND RELATED METHODS | JUSTICE, GINA CHIEUN YU | 1617 | §101Other | Non-Final OA | — | Pending | Nov 22, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialExela Pharma Sciences LLC has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Gina Chieun Yu Justice has the most, with 1 of Exela Pharma Sciences LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.